CIK 1940272
ADAR1 Capital Management, LLC
Institutional 13F holdings & portfolio
Holdings
512
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
1
Holdings
13F filings as of Dec 31, 2025 · Showing 101–150 of 512
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| TARA | PROTARA THERAPEUTICS INC | 1.1M | $1M+ | SH |
| PCSC | PERCEPTIVE CAP SOLUTIONS COR | 457K | $1M+ | SH |
| DHR | DANAHER CORPORATION | 26K | $1M+ | SH |
| DHR | DANAHER CORPORATION | 26K | $1M+ | SH |
| CLYM | CLIMB BIO INC | 1.4M | $1M+ | SH |
| CLYM | CLIMB BIO INC | 1.4M | $1M+ | SH |
| QURE | UNIQURE NV | 235K | $1M+ | SH |
| QURE | UNIQURE NV | 235K | $1M+ | SH |
| RYTM | RHYTHM PHARMACEUTICALS INC | 51K | $1M+ | SH |
| RYTM | RHYTHM PHARMACEUTICALS INC | 51K | $1M+ | SH |
| OACCU | OAKTREE ACQUISITION CORP III | 516K | $1M+ | SH |
| OACCU | OAKTREE ACQUISITION CORP III | 516K | $1M+ | SH |
| ASND | ASCENDIS PHARMA A/S | 25K | $1M+ | SH |
| ASND | ASCENDIS PHARMA A/S | 25K | $1M+ | SH |
| AGIO | AGIOS PHARMACEUTICALS INC | 188K | $1M+ | SH |
| AGIO | AGIOS PHARMACEUTICALS INC | 188K | $1M+ | SH |
| SPRB | SPRUCE BIOSCIENCES INC | 58K | $1M+ | SH |
| SPRB | SPRUCE BIOSCIENCES INC | 58K | $1M+ | SH |
| MLYS | MINERALYS THERAPEUTICS INC | 136K | $1M+ | SH |
| MLYS | MINERALYS THERAPEUTICS INC | 136K | $1M+ | SH |
| KRYS | KRYSTAL BIOTECH INC | 20K | $1M+ | SH |
| KRYS | KRYSTAL BIOTECH INC | 20K | $1M+ | SH |
| PALI | PALISADE BIO INC | 2.0M | $1M+ | SH |
| PALI | PALISADE BIO INC | 2.0M | $1M+ | SH |
| SPRY | ARS PHARMACEUTICALS INC | 370K | $1M+ | SH |
| SPRY | ARS PHARMACEUTICALS INC | 370K | $1M+ | SH |
| BIIB | BIOGEN INC | 24K | $1M+ | SH |
| BIIB | BIOGEN INC | 24K | $1M+ | SH |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 119K | $1M+ | SH |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 119K | $1M+ | SH |
| AEXA | AMERICAN EXCEPTIONALISM ACQU | 358K | $1M+ | SH |
| AEXA | AMERICAN EXCEPTIONALISM ACQU | 358K | $1M+ | SH |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 58K | $1M+ | SH |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 58K | $1M+ | SH |
| ATAI | ATAI BECKLEY NV | 913K | $1M+ | SH |
| ATAI | ATAI BECKLEY NV | 913K | $1M+ | SH |
| CRVS | CORVUS PHARMACEUTICALS INC | 466K | $1M+ | SH |
| CRVS | CORVUS PHARMACEUTICALS INC | 466K | $1M+ | SH |
| JANX | JANUX THERAPEUTICS INC | 245K | $1M+ | SH |
| JANX | JANUX THERAPEUTICS INC | 245K | $1M+ | SH |
| GLUE | MONTE ROSA THERAPEUTICS INC | 216K | $1M+ | SH |
| GLUE | MONTE ROSA THERAPEUTICS INC | 216K | $1M+ | SH |
| AVDL | AVADEL PHARMACEUTICALS PLC | 151K | $1M+ | SH |
| AVDL | AVADEL PHARMACEUTICALS PLC | 151K | $1M+ | SH |
| CTNM | CONTINEUM THERAPEUTICS INC | 279K | $1M+ | SH |
| CTNM | CONTINEUM THERAPEUTICS INC | 279K | $1M+ | SH |
| EVMN | EVOMMUNE INC | 184K | $1M+ | SH |
| EVMN | EVOMMUNE INC | 184K | $1M+ | SH |
| GUTS | FRACTYL HEALTH INC | 1.4M | $1M+ | SH (Call) |
| GUTS | FRACTYL HEALTH INC | 1.4M | $1M+ | SH (Call) |